ROSEN, A LONGSTANDING LAW FIRM, Encourages Nikola Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – NKLA
NEW YORK, Nov. 12, 2023 /PRNewswire/ — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Nikola Corporation (NASDAQ: NKLA) between February 24, 2022 and September 7, 2023, both dates inclusive (the “Class Period”), of the important Decemb
NextEra Energy and NextEra Energy Partners to participate in EEI Financial Conference and meet with investors throughout November and December
JUNO BEACH, Fla., Nov. 12, 2023 /PRNewswire/ — NextEra Energy, Inc. (NYSE: NEE) and NextEra Energy Partners, LP (NYSE: NEP) today announced that members of the senior management team will participate in the EEI Financial Conference from Sunday, Nov. 12, 2023, through Tuesday, Nov. 14, 2023
First Patient Dosed in Phase III ProstACT GLOBAL Study of Antibody-based Prostate Cancer Therapy Candidate, TLX591
MELBOURNE, Australia, Nov. 13, 2023 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the first patient has been dosed in the Company’s Phase III ProstACT GLOBAL study of its investigational prostate-specific membrane antigen (PSMA) targetin
PillWork Strengthens Global Ties Ahead of 2023 Launch with Strategic Partnerships
SEOUL, South Korea, Nov. 12, 2023 /PRNewswire/ — PillWork, emerging as a pioneer in holistic wellness, is meticulously preparing for its anticipated launch at the end of 2023. As part of this build-up, PillWork has gained a place in the AWS Global Collaboration Program, ensuring top-tier app f
Guardant Health launches Shield blood-based screening test for colorectal cancer in South Korea
SINGAPORE, Nov. 13, 2023 /PRNewswire/ — Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, announced that it has launched its blood-based colorectal cancer screening test, ShieldTM, in collaboration with Samsung Medical Center in South Korea. Colorectal cancer (CRC) is o
Ascletis Announces Poster Presentations at AASLD Annual Meeting 2023 Including a Late-Breaking Abstract of Interim Results from Phase IIb Expansion Cohort of ASC22 for Functional Cure of CHB
HANGZHOU and SHAOXING, China, Nov. 12, 2023 /PRNewswire/ — Ascletis Pharma Inc. (HKEX: 1672, “Ascletis”) today announces late-breaking abstract poster presentation of interim results from Phase IIb expansion cohort of ASC22 (Envafolimab) for functional cure of chronic hepatitis B (
Media Advisory – Prime Minister’s itinerary for Monday, November 13, 2023
OTTAWA, ON, Nov. 12, 2023 /CNW/ – Note: All times local Greater Toronto Area, Ontario 10:40 a.m. The Prime Minister will visit a local grocery store. Note for media: Pooled photo opportunity 1:00 p.m. The Prime Minister will mark Bandi Chhor Divas and Diwali with seniors at
Gillette & Braun sign Major Partnership with Movember
SYDNEY, Nov. 13, 2023 /PRNewswire/ — In Australia, one in five men will be diagnosed with prostate cancer in their lifetime. One man globally dies by suicide every minute. Testicular cancer is the most common cancer among younger men. This November, Procter & Gamble’s leading groomi
ROSEN, A LONGSTANDING LAW FIRM, Encourages DLocal Limited Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – DLO
NEW YORK, Nov. 12, 2023 /PRNewswire/ — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of DLocal Limited (NASDAQ: DLO) between May 2, 2022 and May 25, 2023, both dates inclusive (the “Class Period”), of the important December 5, 2023 lead pl
Xinhua Silk Road: Lotus festival in E. China’s Nanchang county yields fruitful economic and trade results
BEIJING, Nov. 12, 2023 /PRNewswire/ — The 7th Lotus Economic, Trade and Cultural Festival has recently concluded in Nanchang County (Xiaolan Economic and Technological Development Zone), east China’s Jiangxi Province. Spanning three months, the comprehensive event included over 40 activ
